Home › Lupus › District of Columbia › Washington

Pag-aaral pangklinika para sa Lupus sa Washington, DC

Isang pag-aaral para sa Lupus ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Washington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Nagre-recruitPhase 1

MedStar Georgetown University Hospital, Washington D.C.
National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT03816345

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Nagre-recruitPhase 3

Research Site, Washington D.C.

Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05835310

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Nagre-recruitObservasyonal na pag-aaral

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda · 7 mi ang layo

Edad 18 hanggang 120 · Kababaihan · Na-update Set 28, 2026 · NCT05567198

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Nagre-recruitPhase 3

Research Site, Silver Spring · 7 mi ang layo

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07430306

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

Nagre-recruitPhase 2

National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05440422

Study of Systemic Lupus Erythematosus

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo

Edad 3 hanggang 120 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT00001372

Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus

Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo

National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo

Edad 18 hanggang 120 · Kababaihan · Na-update Hul 31, 2026 · NCT06032923

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

Nagre-recruitObservasyonal na pag-aaral

Children's National Health System, Washington D.C.

Edad 5 hanggang 21 · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT04833465

Lupus Landmark Study: A Prospective Registry and Biorepository

Nagre-recruitObservasyonal na pag-aaral

Georgetown University, Washington D.C.

Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT05934149

Research Accelerated by You Lupus Registry

Nagre-recruitObservasyonal na pag-aaral

Online Registry - No Physical Site Required, Washington D.C.

Lahat ng edad · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT06927219

Pag-aaral para sa Lupus sa ibang lungsod

Iba pang pag-aaral sa Washington

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.